Loading...

Guillaume Bourque

Home / Investigators  / Guillaume Bourque

Guillaume Bourque

Professor, Department of Human Genetics

Email: guil.bourque@mcgill.ca
Phone: (514) 398-8602
Fax: (514) 398-1790

740 Dr Penfield Ave, Room 6103
Montréal, Québec, Canada, H3A 1A4

Website

Dr. Bourque joined McGill University in 2010 and is a Professor in the Department of Human Genetics and the Director of Bioinformatics at the McGill Genome Center. During his PhD, he worked on genome rearrangements in evolution with Pavel Pevzner at the University of Southern California. From 2004 to 2010, he worked at the Genome Institute of Singapore, where he was a Senior Group Leader and the Associate Director of Computational & Mathematical Biology. Dr. Bourque leads the Canadian Center for Computational Genomics (C3G), a Genome Canada bioinformatics platform, and the McGill initiative in Computational Medicine (MiCM). He is also the head of the Epigenomics Mapping Center at McGill, a project that oversees data generation and processing as part of the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC), which is associated with the International Human Epigenome Consortium (IHEC). He is also the chair of the Integrative Analysis working group of IHEC.

Dr. Bourque is a member of the Advisory Board of CIHR’s Institute of Genetics and is on the External Consultant Panel of the US-funded Encyclopedia of DNA Elements (ENCODE) project. He is also on the Steering Committee of the Global Alliance for Genomics and Health (GA4GH) since two of his projects, CanDIG and EpiShare, have been selected as Driver Projects by the organization. Dr. Bourque is also on the Research Advisory Council of Compute Canada, the national platform for high-performance computing, and of CANARIE, responsible for Canada’s ultra-fast network backbone. In 2019, his leadership in Digital Research Infrastructure was recognized and he was named as one of the 4 Directors of the Applicant Board of the new organization that will coordinate these efforts for Canada. This new organization is funded by the Ministry of Innovation, Science and Economic Development Canada (ISED), with a budget of 375 M$ over the next 5 years, to deploy and coordinate a national infrastructure (covering high-performance computing, software and data management) that will support all areas of research.

Research Interests

The goal of the Bourque lab is to understand mammalian genomes using comparative genomic and epigenomic analyses. Areas of interest include: the evolution of regulatory sequences, the role of transposable elements in gene regulation and the impact of genome rearrangements in evolution and cancer. Work in the lab involves examining the billions of DNA base pairs and interpreting how variation impacts basic biology and disease. One objective is to develop computational methods and resources for the functional annotation of genomes with a special emphasis on sequencing-based assays (e.g. ChIP-seq, RNA-Seq, exome- and whole-genome sequencing, single-cell analysis). Dr. Bourque is also in an ideal position to contribute and drive large health initiatives that have a strong genomic and bioinformatics component. His lab develops advanced tools and scalable computational infrastructure to enable large-scale applied research projects.

Recent Publications

  • Alexandrov, LB, Kim, J, Haradhvala, NJ, Huang, MN, Tian Ng, AW, Wu, Y et al.. Author Correction: The repertoire of mutational signatures in human cancer. Nature. 2023; :. doi: 10.1038/s41586-022-05600-5. PubMed PMID:36697836 .
  • Li, Y, Roberts, ND, Wala, JA, Shapira, O, Schumacher, SE, Kumar, K et al.. Author Correction: Patterns of somatic structural variation in human cancer genomes. Nature. 2023; :. doi: 10.1038/s41586-022-05597-x. PubMed PMID:36697835 .
  • ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Author Correction: Pan-cancer analysis of whole genomes. Nature. 2023; :. doi: 10.1038/s41586-022-05598-w. PubMed PMID:36697834 .
  • Gerstung, M, Jolly, C, Leshchiner, I, Dentro, SC, Gonzalez, S, Rosebrock, D et al.. Author Correction: The evolutionary history of 2,658 cancers. Nature. 2023; :. doi: 10.1038/s41586-022-05601-4. PubMed PMID:36697833 .
  • Rheinbay, E, Nielsen, MM, Abascal, F, Wala, JA, Shapira, O, Tiao, G et al.. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2023; :. doi: 10.1038/s41586-022-05599-9. PubMed PMID:36697832 .
  • PCAWG Transcriptome Core Group, Calabrese, C, Davidson, NR, Demircioğlu, D, Fonseca, NA, He, Y et al.. Author Correction: Genomic basis for RNA alterations in cancer. Nature. 2023; :. doi: 10.1038/s41586-022-05596-y. PubMed PMID:36697831 .
  • da Silva, SD, Morand, GB, Diesel, L, de Lima, JM, Bijian, K, Kailasam, S et al.. Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV600E-Positive Papillary Thyroid Cancer. Cells. 2022;12 (1):. doi: 10.3390/cells12010139. PubMed PMID:36611933 PubMed Central PMC9818556.
  • Carlevaro-Fita, J, Lanzós, A, Feuerbach, L, Hong, C, Mas-Ponte, D, Pedersen, JS et al.. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun Biol. 2022;5 (1):1347. doi: 10.1038/s42003-022-03769-z. PubMed PMID:36482178 PubMed Central PMC9732278.
  • Rubanova, Y, Shi, R, Harrigan, CF, Li, R, Wintersinger, J, Sahin, N et al.. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun. 2022;13 (1):7567. doi: 10.1038/s41467-022-32336-7. PubMed PMID:36482170 PubMed Central PMC9731941.
  • Sieverling, L, Hong, C, Koser, SD, Ginsbach, P, Kleinheinz, K, Hutter, B et al.. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun. 2022;13 (1):7574. doi: 10.1038/s41467-022-32328-7. PubMed PMID:36481818 PubMed Central PMC9731961.
Search PubMed